COSCIA, Marta
 Distribuzione geografica
Continente #
NA - Nord America 2.439
EU - Europa 1.141
AS - Asia 624
SA - Sud America 32
OC - Oceania 27
AF - Africa 20
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.285
Nazione #
US - Stati Uniti d'America 2.386
IT - Italia 478
CN - Cina 309
DE - Germania 145
FR - Francia 103
GB - Regno Unito 86
VN - Vietnam 69
IN - India 61
JP - Giappone 49
CZ - Repubblica Ceca 47
CA - Canada 46
KR - Corea 38
IE - Irlanda 35
RU - Federazione Russa 34
ES - Italia 32
AU - Australia 24
HK - Hong Kong 22
NL - Olanda 22
PL - Polonia 18
SE - Svezia 18
TW - Taiwan 16
CL - Cile 14
AT - Austria 13
SG - Singapore 13
BR - Brasile 12
CH - Svizzera 12
ZA - Sudafrica 12
FI - Finlandia 11
RO - Romania 11
UA - Ucraina 11
TR - Turchia 10
MT - Malta 9
PT - Portogallo 9
GR - Grecia 8
HU - Ungheria 7
IL - Israele 7
MK - Macedonia 7
BE - Belgio 6
DK - Danimarca 5
EG - Egitto 5
IR - Iran 5
SK - Slovacchia (Repubblica Slovacca) 5
TT - Trinidad e Tobago 5
MY - Malesia 4
TH - Thailandia 4
CO - Colombia 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
QA - Qatar 3
SA - Arabia Saudita 3
SI - Slovenia 3
AR - Argentina 2
IQ - Iraq 2
LT - Lituania 2
LU - Lussemburgo 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BJ - Benin 1
BY - Bielorussia 1
CY - Cipro 1
EC - Ecuador 1
ET - Etiopia 1
EU - Europa 1
HN - Honduras 1
ID - Indonesia 1
LB - Libano 1
MO - Macao, regione amministrativa speciale della Cina 1
MX - Messico 1
NO - Norvegia 1
PH - Filippine 1
TN - Tunisia 1
Totale 4.285
Città #
Fairfield 239
Ashburn 204
Santa Cruz 170
Torino 154
Houston 153
Seattle 141
Buffalo 114
Woodbridge 93
Wilmington 75
Cambridge 71
Ann Arbor 64
Shanghai 56
Beijing 53
Dong Ket 53
Chicago 52
Turin 37
Los Angeles 35
San Diego 33
Dublin 32
Shenyang 32
New York 27
Mountain View 23
Ottawa 23
Dallas 21
Milan 19
University Park 19
Las Vegas 18
Frankfurt Am Main 17
Henderson 17
Wuhan 17
Warsaw 16
Guangzhou 15
Stuttgart 15
Chennai 14
Nanjing 14
Pisa 14
Taipei 14
Centro 13
Chengdu 13
Columbus 13
London 12
San Francisco 12
Bengaluru 11
Boardman 11
Clearwater 11
Duncan 11
Muizenberg 11
Philadelphia 11
Southampton 11
Tokyo 11
Rochester 10
San Jose 10
Tortorici 10
Boston 9
Provo 9
Rome 9
Seoul 9
Xian 9
Atlanta 8
Helsinki 8
Menlo Park 8
Phoenix 8
Amsterdam 7
Genova 7
Hyderabad 7
Lake Forest 7
Providence 7
Redmond 7
Athens 6
Barcelona 6
Changchun 6
Chongqing 6
Dunstable 6
Hangzhou 6
Madrid 6
Milazzo 6
Brookline 5
Bucharest 5
Castiglione 5
Chandler 5
Council Bluffs 5
Des Moines 5
Detroit 5
Heidelberg 5
Luton 5
Melbourne 5
Miami 5
Münster 5
Port of Spain 5
Prilep 5
Ürümqi 5
Charlestown 4
Glasgow 4
Hedemora 4
La Jolla 4
Monteriggioni 4
Munich 4
Natters 4
Pezinok 4
Raritan 4
Totale 2.623
Nome #
Adoptive immunotherapy with CAR modified T cells in cancer: current landscape and future perspectives, file e27ce42e-9d5b-2581-e053-d805fe0acbaa 494
Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter's syndrome: therapeutic implications., file e27ce42e-638f-2581-e053-d805fe0acbaa 492
Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia., file e27ce42a-6aab-2581-e053-d805fe0acbaa 401
The PD-1/PD-L1 axis contributes to T cell dysfunction in chronic lymphocytic leukemia., file e27ce426-e59e-2581-e053-d805fe0acbaa 231
Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma, file e27ce427-79db-2581-e053-d805fe0acbaa 231
Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cells, file e27ce427-83a5-2581-e053-d805fe0acbaa 206
The Advent of CAR T-Cell Therapy for Lymphoproliferative Neoplasms: Integrating Research Into Clinical Practice, file e27ce430-d7e2-2581-e053-d805fe0acbaa 156
IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells, file e27ce426-c0e0-2581-e053-d805fe0acbaa 152
Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: Correlation with biologically-based risk stratification, file e27ce42c-a6fd-2581-e053-d805fe0acbaa 136
Mutations in NOTCH1 PEST-domain orchestrate CCL19-driven homing of Chronic Lymphocytic Leukemia cells by modulating the tumor suppressor gene DUSP22, file e27ce42a-bdbe-2581-e053-d805fe0acbaa 124
A phase II multi-center trial of pentostatin plus cyclophosphamide with ofatumumab in older previously untreated chronic lymphocytic leukemia patients, file e27ce429-3c2a-2581-e053-d805fe0acbaa 114
SLAMF1 regulation of chemotaxis and autophagy determines CLL patient response, file e27ce42a-93b5-2581-e053-d805fe0acbaa 106
Magic pills: new oral drugs to treat chronic lymphocytic leukemia, file e27ce42b-6be3-2581-e053-d805fe0acbaa 105
Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study, file e27ce430-c16b-2581-e053-d805fe0acbaa 100
Autoimmune complications in chronic lymphocytic leukemia in the era of targeted drugs, file e27ce42f-ab31-2581-e053-d805fe0acbaa 95
HIF-1α is overexpressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia, file e27ce42e-ef9d-2581-e053-d805fe0acbaa 92
Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib–rituximab, file e27ce430-d7e7-2581-e053-d805fe0acbaa 92
Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia, file e27ce42a-8c1f-2581-e053-d805fe0acbaa 85
Elevated lactate dehydrogenase has prognostic relevance in treatment-naïve patients affected by chronic lymphocytic leukemia with trisomy 12, file e27ce42f-52b0-2581-e053-d805fe0acbaa 78
Real life use of bendamustine in elderly patients with lymphoid neoplasia, file e27ce432-2046-2581-e053-d805fe0acbaa 74
Immunotherapeutic strategies in chronic lymphocytic leukemia: advances and challenges, file e27ce434-b0d8-2581-e053-d805fe0acbaa 73
Old and New Drugs for Chronic Lymphocytic Leukemia: Lights and Shadows of Real-World Evidence, file e27ce435-5dbe-2581-e053-d805fe0acbaa 67
HIF-1α is overexpressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia, file e27ce430-5244-2581-e053-d805fe0acbaa 65
Targeting hif-1α regulatory pathways as a strategy to hamper tumor-microenvironment interactions in cll, file e27ce432-7ca5-2581-e053-d805fe0acbaa 57
High rate of MRD-responses in young and fit patients with IGHV mutated chronic lymphocytic leukemia treated with front-line fludarabine, cyclophosphamide, and intensified dose of ofatumumab (FCO2), file e27ce430-a20b-2581-e053-d805fe0acbaa 51
Cd200 baseline serum levels predict prognosis of chronic lymphocytic leukemia, file e27ce432-33fb-2581-e053-d805fe0acbaa 50
Prognostic relevance of oxidative stress measurement in chronic lymphocytic leukaemia, file e27ce42b-eff7-2581-e053-d805fe0acbaa 49
Prognostic significance of PET/CT in patients with chronic lymphocytic leukemia (CLL) treated with frontline chemoimmunotherapy, file e27ce430-d7ea-2581-e053-d805fe0acbaa 48
Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real-life campus CLL study, file e27ce434-84a6-2581-e053-d805fe0acbaa 48
Impact of immune parameters and immune dysfunctions on the prognosis of patients with chronic lymphocytic leukemia, file e27ce432-2f60-2581-e053-d805fe0acbaa 41
Zoledronic Acid Restores Doxorubicin Chemosensitivity and Immunogenic Cell Death in Multidrug-Resistant Human Cancer Cells, file e27ce426-e647-2581-e053-d805fe0acbaa 40
Regulation of HIF-1α in TP53 Disrupted Chronic Lymphocytic Leukemia Cells and Its Potential Role as a Therapeutic Target, file e27ce42e-24b0-2581-e053-d805fe0acbaa 39
Centralized Biobanking Supports Hematology Clinical Trials: the new challenge of the University of Torino, file e27ce42e-70fd-2581-e053-d805fe0acbaa 38
Prognostic impact and risk factors of infections in patients with chronic lymphocytic leukemia treated with ibrutinib, file e27ce432-6f0a-2581-e053-d805fe0acbaa 36
Case Report: Sequential Development of Three Mature Lymphoid Neoplasms in a Single Patient: Clonal Relationship and Molecular Insights, file 79f96122-4c5d-4b19-a66a-786e84540e13 28
Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three-factor model, file e27ce434-e83c-2581-e053-d805fe0acbaa 27
Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma, file e27ce427-b3d4-2581-e053-d805fe0acbaa 17
BTK and PLCG2 remain unmutated in one third of patients with CLL relapsing on ibrutinib, file b2657a55-92a0-4fd1-8f8d-78bf4d30f7e0 12
Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study, file 0817f5cc-ee83-49d2-98fc-280183402ab5 11
Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study, file f5cfad19-82df-42a0-bc27-958e510cc815 11
Effector gammadelta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma, file e27ce426-aeab-2581-e053-d805fe0acbaa 10
Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: Evidences from long term follow-up, file e27ce42c-a111-2581-e053-d805fe0acbaa 7
IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells, file e27ce426-c0e1-2581-e053-d805fe0acbaa 6
Idiotype vaccination in human myeloma: generation of tumor-specific immune responses after high-dose chemotherapy., file e27ce42a-c7d6-2581-e053-d805fe0acbaa 6
Netupitant-palonosetron to prevent chemotherapy-induced nausea and vomiting in multiple myeloma patients receiving high-dose melphalan and autologous stem cell transplantation, file e27ce430-1511-2581-e053-d805fe0acbaa 6
Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: A GIMEMA, ERIC and UK CLL FORUM study, file e27ce432-5148-2581-e053-d805fe0acbaa 6
Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL, file 563bac55-0461-4c9c-8eae-a9e1c40bbc84 5
High rate of durable responses with undetectable minimal residual disease with frontline venetoclax and rituximab in young and fit patients with chronic lymphocytic leukemia and an adverse biologic profile: results of the gimema phase II LLC1518 - 'Veritas' study, file 64042bde-855f-4f15-893a-87806cc7eecc 5
The immunomodulatory molecule TIGIT is expressed by chronic lymphocytic leukemia cells and contributes to anergy, file 7a8e79fe-b3ab-4f2f-af0e-13207738464d 5
Severe and long-lasting disruption of T-cell receptor diversity in human myeloma after high-dose chemotherapy and autologous peripheral blood progenitor cell infusion., file e27ce42a-b7d4-2581-e053-d805fe0acbaa 5
Coexisting conditions and concomitant medications do not affect venetoclax management and survival in chronic lymphocytic leukemia, file 07df7579-f01c-4a60-afc4-c5a8b1de867a 4
Exposure to myeloma cell lysates affects the immune competence of dendritic cells and favors the induction of Tr1-like regulatory T cells, file e27ce426-b455-2581-e053-d805fe0acbaa 4
Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia., file e27ce432-593f-2581-e053-d805fe0acbaa 4
Immune Modulation by Zoledronic Acid in Human Myeloma: An Advantageous Cross Talk between V{gamma}9V{delta}2 T Cells, {alpha}{beta} CD8+ T Cells, Regulatory T Cells, and Dendritic Cells, file e27ce426-d90d-2581-e053-d805fe0acbaa 3
Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter's syndrome: therapeutic implications., file e27ce432-55cb-2581-e053-d805fe0acbaa 3
Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL: Two-Year Follow-Up of a Multicenter Study, file 70f16a90-befe-4e60-815c-e7e5232e2876 2
IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells, file e27ce426-c0df-2581-e053-d805fe0acbaa 2
Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells., file e27ce426-ef1f-2581-e053-d805fe0acbaa 2
Mutations in NOTCH1 PEST-domain orchestrate CCL19-driven homing of Chronic Lymphocytic Leukemia cells by modulating the tumor suppressor gene DUSP22, file e27ce432-5940-2581-e053-d805fe0acbaa 2
The immunomodulatory molecule TIGIT is expressed by chronic lymphocytic leukemia cells and contributes to anergy, file 0c2b5320-cadd-4342-b1cd-417f15ffb1aa 1
Anti-tumor activity of selinexor in combination with antineoplastic agents in chronic lymphocytic leukemia, file 28786943-7cfe-4e63-83ba-0c5952e029bf 1
CAR-modified Cellular Therapies in Chronic Lymphocytic Leukemia: Is the Uphill Road Getting Less Steep?, file 312f13fb-4af7-48e6-a7fa-6240f59d17c3 1
Efficacy of front-line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter “Real-World” study, file da188058-e88e-45d8-b75c-34a17dd05416 1
Zoledronic acid repolarizes tumor-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway, file e27ce426-b3b3-2581-e053-d805fe0acbaa 1
CD73-Generated Extracellular Adenosine Creates Microenvironmental Conditions Favoring Growth and Survival of Chronic Lymphocytic Leukemia Cells, file e27ce426-ee03-2581-e053-d805fe0acbaa 1
Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia, file e27ce42a-be6b-2581-e053-d805fe0acbaa 1
Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment, file e27ce42a-c99b-2581-e053-d805fe0acbaa 1
Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY, file f65f4953-cfab-451d-b00d-5b440aab43b0 1
Totale 4.468
Categoria #
all - tutte 7.124
article - articoli 0
book - libri 0
conference - conferenze 170
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.294


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019161 0 0 0 0 0 0 0 0 0 37 71 53
2019/2020498 41 18 22 52 40 32 53 46 51 49 45 49
2020/2021991 70 95 70 67 130 56 104 66 52 108 56 117
2021/20221.126 94 60 65 98 101 88 74 75 55 105 224 87
2022/2023890 26 42 187 96 38 51 57 109 182 38 54 10
2023/2024301 33 14 35 22 39 27 54 51 17 9 0 0
Totale 4.468